Prostate Cancer and Prostatic Diseases
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.9 | Q1 | 91.0% | 2.025 | Q1 | 95.3% |
| 2024 | 5.8 | Q1 | 92.5% | 1.962 | Q1 | 95.1% |
| 2023 | 5.1 | Q1 | 91.3% | 1.711 | Q1 | 94.2% |
| 2022 | 4.8 | Q1 | 88.8% | 1.676 | Q1 | 94.2% |
| 2021 | 5.5 | Q1 | 86.6% | 1.519 | Q1 | 93.3% |
| 2020 | — | — | 2.000 | Q1 | 95.6% | |
| 2019 | — | — | 1.830 | Q1 | 94.9% | |
| 2018 | — | — | 2.200 | Q1 | 95.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1476-5608
ISSN
1365-7852
country
GBcoverage
1997-2026